Immobilization heparin/type Ⅳ collagen onto titanium surface for improving the biocompatibility

ZHANG Kun,DENG Kun,LI Jing-an,WANG Xue,CHEN Jun-ying,HUANG Nan

DOI: https://doi.org/10.3969/j.issn.1001-9731.2012.24.009

2012-01-01

Abstract:Endothelialization is a good way to obtain ultimate long-term compatibility of the interfaces between stents and blood or/and tissue.Rapid endothelialization on the biomaterials surface is possible through the aggregation,growth and proliferation of endothelial progenitor cells.In this paper,the anti-clotting drug of heparin and type Ⅳ collagen as a main component of basement membrane were combined onto the titanium surface to improve the biocompatibility.The formation of positively charged amino surface on titanium was firstly completed after alkali activation and silane treatment.The residual negative charges of heparin/type Ⅳ collagen complex were then combined to the positively charged amino surface via electrostatic interaction.The change of the groups on the surface was detected by the Fourier transform infrared spectroscopy.The water contact angle measurement and scanning electron microscopy were used to track the surface hydrophilic and hydrophobic properties and surface morphology changes.Qualitative characterization of type Ⅳ collagen and the morphology of endothelial progenitor cells were detected by immunofluorescence staining.The results showed that the bioinspired layer was successfully constructed.In compared with titanium,the bionic modified surface had more endothelial progenitor cells(EPCs) adhesion,more rapid cell growth and proliferation,and better cell morphology.It was concluded that the cell compatibility was significantly improved due to the biological modification on materials surface.The introductions of type Ⅳ collagen to materials surface provide an important pathway for the surface modification of cardiovascular implants.